DSM-5: A collection of psychiatrist views on the changes, controversies, and future directions

Charles B. Nemeroff*, Daniel Weinberger, Michael Rutter, Harriet L. MacMillan, Richard A. Bryant, Simon Wessely, Dan J. Stein, Carmine M. Pariante, Florian Seemüller, Michael Berk, Gin S. Malhi, Martin Preisig, Martin Brüne, Paul Lysaker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Abstract

The recent release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) by the American Psychiatric Association has led to much debate. For this forum article, we asked BMC Medicine Editorial Board members who are experts in the field of psychiatry to discuss their personal views on how the changes in DSM-5 might affect clinical practice in their specific areas of psychiatric medicine. This article discusses the influence the DSM-5 may have on the diagnosis and treatment of autism, trauma-related and stressor-related disorders, obsessive-compulsive and related disorders, mood disorders (including major depression and bipolar disorders), and schizophrenia spectrum disorders.

Original languageEnglish
Article number202
JournalBMC Medicine
Volume11
Issue number1
DOIs
StatePublished - 12 Sep 2013
Externally publishedYes

Funding

FundersFunder number
Medical Research Council
National Institute for Health and Care Research
Eli Lilly and Company
National Institutes of Health
Agency for Healthcare Research and Quality
Glaxo-Smith Kline
AstraZeneca

    Keywords

    • Autism
    • Bipolar
    • Depression
    • DSM-5
    • Mood disorders
    • Obsessive-compulsive disorders
    • Psychiatry
    • PTSD
    • Schizophrenia

    Fingerprint

    Dive into the research topics of 'DSM-5: A collection of psychiatrist views on the changes, controversies, and future directions'. Together they form a unique fingerprint.

    Cite this